University of Southern California

Funding Organization

Awards Grant

  • A Genome Wide Admixture Scan of Multiple Myeloma in African-Americans
  • Alzheimer's Clinical Trials Consortium (ACTC) (U24)
  • Alzheimer's Disease Cooperative Study - A4 Study
  • Alzheimer's Disease Cooperative Study - A4 Study
  • Alzheimer's Disease Neuroimaging Initiative 2 (ADNI2)
  • Alzheimer's Disease Neuroimaging Initiative 3 (ADNl3)
  • Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
  • Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Open-Label Extension Study
  • Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease(A4 Study)
  • Combination Anti-Amyloid Therapy for Preclinical Alzheimer's Disease
  • Effects of Traumatic Brian Injury and Post-Traumatic Stress Disorder and Alzheimer's Disease on Brain Tau in Vietnam Veterans using ADNI
  • Global Alzheimer’s Platform Trial-Ready Cohort for Preclinical/Prodromal Alzheimer’s Disease
  • In-Home Obesity Prevention to Reach Low-Income Infants Through Maternal and Social Transmission
  • Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study A Companion Observational Study to Antl-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
  • Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study: A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
  • Mechanistic Approaches to Inhibition of Emerging DNA Viruses
  • Small Molecule Inhibitors Targeting Adenovirus
  • Small Molecule Inhibitors Targeting Adenovirus
  • Synthesis of Longer-Term Alzheimer Disease Studies in Order to Model and Improve Clinical Trials Methods and Outcomes: Alzheimer Disease Clinical
  • Tau PET Imaging for the USC Alzheimer's Therapeutic Research Institute (USC ATRI) A4 Trial (“A4 TAU”)
  • The A3 Study: Ante-Amyloid Prevention of Alzheimer's Disease